Liverpool Pneumonia Vaccine Research

About Liverpool Pneumonia Vaccine Research

We are developing a new vaccine to protect against bacteria called Pneumococcus.

We invite volunteers to have a few drops of the bacteria in the nose followed by careful monitoring. (You will be paid for your time and inconvenience)

Small numbers of these bacteria are often found in the nose. Usually, the carrier does not know the bacteria are there. In most adults this is present at least once per year and more often in children. We think that small numbers of bacteria present in the nose (“nasal carriage”) can help to protect people against disease.

Mild infections with pneumococcus are very common, such as ear infections in children. But pneumococcus can also infect the lung (causing pneumonia) or the brain (causing meningitis) or the blood (causing sepsis). These severe infections are very uncommon in healthy adults: about 50 cases in Liverpool per year. Very young children and adults who are elderly (mainly those who have other illnesses) are more likely to become ill.

We may be able to protect people against severe disease from pneumococcus using a vaccine which could be sprayed into the nose. We don’t yet know if this will work.

To test the idea, our research team want to study what happens when small numbers of the bacteria are put up the nose of healthy volunteers. We have already studied this using more than 500 volunteers, and have found this type of study to be safe.

Liverpool Pneumonia Vaccine Research Description

We are developing a new vaccine to protect against bacteria called Pneumococcus.

We invite volunteers to have a few drops of the bacteria in the nose followed by careful monitoring. (You will be paid for your time and inconvenience)

Small numbers of these bacteria are often found in the nose. Usually, the carrier does not know the bacteria are there. In most adults this is present at least once per year and more often in children. We think that small numbers of bacteria present in the nose (“nasal carriage”) can help to protect people against disease.

Mild infections with pneumococcus are very common, such as ear infections in children. But pneumococcus can also infect the lung (causing pneumonia) or the brain (causing meningitis) or the blood (causing sepsis). These severe infections are very uncommon in healthy adults: about 50 cases in Liverpool per year. Very young children and adults who are elderly (mainly those who have other illnesses) are more likely to become ill.

We may be able to protect people against severe disease from pneumococcus using a vaccine which could be sprayed into the nose. We don’t yet know if this will work.

To test the idea, our research team want to study what happens when small numbers of the bacteria are put up the nose of healthy volunteers. We have already studied this using more than 500 volunteers, and have found this type of study to be safe.

More about Liverpool Pneumonia Vaccine Research

Liverpool Pneumonia Vaccine Research is located at Royal Liverpool University Hospital, Prescot Street,, L7 8XP Liverpool
0151 706 3381
http://www.lstmed.ac.uk/pneumoniavaccine